Please wait while the formulary information is being retrieved.
TRIPLE ANTIBIOTIC (NEOMYCIN SULFATE/BACITRACIN/POLYMYXIN B)
- Minor bacterial skin infections
- Triple Antibiotic Topical Ointment In Packet
- Triple Antibiotic Topical Ointment
- Neosporin (neo-bac-polym) Topical Ointment Packet
- Neosporin (neo-bac-polym) Topical Ointment
- First Aid Antibiotic Topical Ointment
- Antibiotic (neomy-bacit-polym) Topical Ointment
3.5 mg-400 unit-5,000 unit topical ointment in packt
- Dosage information is not available
3.5 mg-400 unit-5,000 unit/gram topical ointment
- Dosage information is not available
(neo-bac-polym) 3.5 mg-400 unit-5,000 unit top ointment packt
- Dosage information is not available
(neo-bac-polym) 3.5 mg-400 unit-5,000 unit/gram top ointment
- Dosage information is not available
3.5 mg-400 unit-5,000 unit/gram topical ointment
- Dosage information is not available
3.5 mg-500 unit-10,000 unit topical ointment
- Dosage information is not available
(neomy-bacit-polym) 3.5 mg-400 unit-5,000 unit/gram top oint
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Severe burns
Severe
Moderate
- Large open wound
- No disease contraindications
TRIPLE ANTIBIOTIC (NEOMYCIN SULFATE/BACITRACIN/POLYMYXIN B)
- Minor bacterial skin infections
- Dermatitis due to topical drug
- Skin rash
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Ototoxicity
Less Severe
- Fungal infection of skin
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Bacitracin (ophth,top)
- Severity Level:
2
- Additional Notes: Insufficient data available.
Neomycin (topical)
- Severity Level:
2
- Additional Notes: Insufficient data available for topical product.
Polymyxin B Sulfate (ophth,otic,top)
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Bacitracin (inj,top,ophth)
Insufficient data available.
Insufficient data available
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
Neomycin (topical, Ophth)
Insufficient data available.
Insufficient data available
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
Polymyxin B
Insufficient data available.
Insufficient data available
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Minor bacterial skin infections | |
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
| 0-9 | A-Z |
|---|---|
| L08.89 | Other specified local infections of the skin and subcutaneous tissue |
| L08.9 | Local infection of the skin and subcutaneous tissue, unspecified |
Formulary Reference Tool